Xatryx bioPTMEG

Qidong, China – September 08, 2026 -- Covation Biomaterials LLC (CovationBio) has produced its first commercial on-spec batches of Xatryx.T bioTHF and Xatryx bioPTMEG at its 50,000-ton Qidong facility, reaching full production status just four months after mechanical completion in April 2026.

Qidong plant clears quality control on three molecular weight grades

Production began in August 2026 and covered Xatryx bioPTMEG in 2000, 1800 and 1000 molecular weight variants alongside Xatryx.T bioTHF. Internal quality control testing confirmed all grades met industry specifications, according to the company.

Qidong – September 08, 2026 -- Covation Biomaterials LLC (CovationBio) has produced its first on-spec commercial batches of Xatryx.T bioTHF and Xatryx® bioPTMEG at its 50,000-ton Qidong plant, four months after the facility's mechanical completion in April 2026. The company simultaneously unveiled the world's first athletic insole made with a non-food bio-based material, developed with insole brand INSITE®, at the NW Materials Show in Portland, Oregon on September 2-3, 2026.